What is Shilpa Medicare Ltd (SHILPAMED) share price today?

Shilpa Medicare Ltd (SHILPAMED) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/SHILPAMED for the latest live price, technical analysis, and AI-powered insights.

How to analyse SHILPAMED stock?

VestAI provides comprehensive SHILPAMED stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Shilpa Medicare Ltd in?

Shilpa Medicare Ltd (SHILPAMED) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Shilpa Medicare Ltd

Name: Shilpa Medicare Ltd (SHILPAMED) Financial Metrics
Creator: VestAI
License: https://www.vestai.io/terms

SHILPAMED

NSE· Healthcare

₹606.70

-13.90 (-2.24%)

52W Low · ₹259.5052W High · ₹860.00

Mid Range

Market Cap

₹10523.28L Cr

Volume

2.73L

Prev Close

₹606.20

ISIN

INE790G01031

Orion Score

Fundamentals-based quality & risk · not a recommendation

45/100

Caution

Shilpa Medicare Ltd scores 45/100 (Caution) on the Orion Score — weak business quality (43), moderate growth (55), weak balance-sheet safety (46) and rich valuation (38). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 2.4× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 5/9Altman Z Safe(6.95)Beneish M Clean(-2.44)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

78/100

Strong

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.25x — lean balance sheet

QUALITY

Average

ROCE 13.2% — decent returns

MOMENTUM

Neutral

RSI 59.2 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 43.29
ROCE: 13.16%
ROE (1Y): 9.82%
D/E Ratio: 0.25x
OPM: 24.27%
TTM EPS: ₹12.43
Dividend Yield: 9.00%
Qtrly Sales: ₹436.99 Cr
Qtrly Profit: ₹107.79 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹436.99	₹107.79	24.3%	₹5.51
Q3 2026	₹409.73	₹44.58	20.5%	₹2.36
Q2 2026	₹369.97	₹44.07	21.2%	₹1.12
Q1 2026	₹321.46	₹46.89	19.5%	₹2.40
Q4 2025	₹330.82	₹14.51	19.6%	₹0.74

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹1,538.87	₹243.33	₹534.75	24.4%
FY 2025	₹1,286.43	₹78.3	₹348.31	18.9%
FY 2024	₹1,151.6	₹31.87	₹245.92	11.6%
FY 2023	₹1,043.45	₹-32.53	₹113.47	-0.4%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
SHILPAMED ★	₹10,523 Cr	43.29	13.16%	9.82%	0.25x	24.27%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹88,148 Cr	25.39	12.55%	9.93%	0.21x	15.11%
ASTERDMAster DM Quality	₹68,390 Cr	104.34	8.93%	10.07%	0.46x	13.98%
ABBOTINDIAAbbott India Limited	₹59,509 Cr	38.28	36.31%	34.46%	0.04x	27.01%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹3,310.71	₹3,093.24	₹2,903.93	₹2,875.5
Equity	₹2,363.07	₹1,801.08	₹1,783.28	₹1,822.19
Total Debt	₹587.75	₹937.39	₹797.89	₹683.29
Cash	₹25.97	₹30.23	₹21.32	₹33.83
Net Debt	₹560.39	₹905.36	₹774.4	₹648.08
Working Capital	₹311.44	₹182.65	₹-14.89	₹275.66

Shareholding Pattern

Q3 FY2026

Promoter

40.13%

FII

10.97%

DII

8.34%

Public

40.56%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q3 FY2026	40.13% ↓	10.97% ↑	8.34% ↑	40.56% ↑
Q2 FY2026	44.23%	10.92% ↓	7.67% ↑	37.18% ↑
Q1 FY2026	44.23%	11.19% ↑	7.46% ↓	37.1% ↓
Q4 FY2025	44.23%	10.97% ↑	7.55% ↓	37.25% ↓
Q3 FY2025	44.23% ↓	9.9% ↑	8.27% ↑	37.59% ↓
Q2 FY2025	44.33% ↓	9.59% ↑	8.18% ↑	37.9% ↓
Q1 FY2025	44.39% ↓	9.08% ↑	7.61% ↑	38.91% ↓
Q4 FY2024	50.01%	5.63%	1.65%	42.71%

Corporate Actions

No recent corporate actions

Smart Money Holdings

Q4 FY2025

Investor	Shares Held	Portfolio %	Change
akash-bhanshali	30,00,000	4.60%	—
akash-bhanshali	15,11,083	1.60%	—

Funds Holding This Stock

22 mutual fund schemes

Aditya Birla Sun Life Pharma & Healthcare Fund Direct GrowthBIRLA_SUN_LIFE

2.92%

₹28 Cr

Bandhan Healthcare Fund Direct GrowthIDFC

2.41%

₹7 Cr

HDFC Pharma And Healthcare Fund Direct GrowthHDFC

2.28%

₹54 Cr

Aditya Birla Sun Life Retirement Fund The 30s Plan Direct GrowthBIRLA_SUN_LIFE

2.09%

₹9 Cr

Aditya Birla Sun Life Manufacturing Equity Fund Direct GrowthBIRLA_SUN_LIFE

1.31%

₹16 Cr

ITI Pharma and Healthcare Fund Direct GrowthITI

1.04%

₹2 Cr

ICICI Prudential Exports and Services Fund Direct GrowthICICI_PRUDENTIAL

0.82%

₹11 Cr

ICICI Prudential ELSS Tax Saver Direct Plan GrowthICICI_PRUDENTIAL

0.76%

₹103 Cr

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct GrowthICICI_PRUDENTIAL

0.71%

₹46 Cr

WhiteOak Capital Special Opportunities Fund Direct GrowthWHITEOAK_CAPITAL

0.64%

₹10 Cr

Analyse SHILPAMED with Orion AI

Ask: "Is Shilpa Medicare Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Shilpa Medicare Ltd (SHILPAMED) Stock

Shilpa Medicare Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE790G01031. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.